| At a glance | 2000 | 2011 | 2021 | 2030 | 2045 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
 United States of America | United States of America | United States of America | United States of America | United States of America | United States of America | United States of America | United States of America | United States of America | United States of America | |
| Diabetes estimates (20-79 y) | ||||||||||
| People with diabetes, in 1,000s | 15,280.0 | 15,280.0 | 23,721.8 | 23,721.8 | 32,215.3 | 32,215.3 | 34,755.3 | 34,755.3 | 36,289.9 | 36,289.9 |
| Age-adjusted comparative prevalence of diabetes, % | - | - | 9.4 | 9.4 | 10.7 | 10.7 | 12.1 | 12.1 | 12.9 | 12.9 |
| People with undiagnosed diabetes, in 1,000s | - | - | - | - | 4,026.9 | 4,026.9 | - | - | - | - |
| Proportion of people with undiagnosed diabetes, % | - | - | - | - | 12.5 | 12.5 | - | - | - | - |
| Impaired glucose tolerance (IGT) estimates (20-79 y) | ||||||||||
| People with IGT, in 1,000s | - | - | 25,948.7 | 25,948.7 | 32,019.0 | 32,019.0 | 34,320.2 | 34,320.2 | 35,690.8 | 35,690.8 |
| Age-adjusted comparative prevalence of IGT, % | - | - | 10.6 | 10.6 | 11.7 | 11.7 | 12.6 | 12.6 | 13.1 | 13.1 |
| Mortality attributable to diabetes (20-79 y) | ||||||||||
| Deaths attributable to diabetes | - | - | 179,612.0 | 179,612.0 | 669,384.0 | 669,384.0 | - | - | - | - |
| Proportion of diabetes-related deaths in people under 60 y, % | - | - | - | - | 3.5 | 3.5 | - | - | - | - |
| Type 1 diabetes estimates in children and adolescents | ||||||||||
| New cases of type 1 diabetes (0-14 y), in 1,000s | 9.6 | 9.6 | 0.2 | 0.2 | 15.3 | 15.3 | - | - | - | - |
| New cases of type 1 diabetes (0-19 y), in 1,000s | - | - | - | - | 18.2 | 18.2 | - | - | - | - |
| Type 1 diabetes (0-14 y), in 1,000s | 57.3 | 57.3 | - | - | 82.3 | 82.3 | - | - | - | - |
| Type 1 diabetes (0-19 y), in 1,000s | - | - | - | - | 157.9 | 157.9 | - | - | - | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||||||||
| Live births affected by HIP | - | - | - | - | 913,054.4 | 913,054.4 | - | - | - | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - | 20.1 | 20.1 | - | - | - | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - | 12,666.4 | 12,666.4 | - | - | - | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - | 88,665.0 | 88,665.0 | - | - | - | - |
| Diabetes-related health expenditure | ||||||||||
| Total diabetes-related health expenditure, USD million | - | - | - | - | 379,470.2 | 379,470.2 | 388,934.4 | 388,934.4 | 392,537.4 | 392,537.4 |
| Total diabetes-related health expenditure, ID million | - | - | - | - | 379,470.2 | 379,470.2 | 388,934.4 | 388,934.4 | 392,537.4 | 392,537.4 |
| Diabetes-related health expenditure per person, USD | - | - | 8,468.0 | 8,468.0 | 11,779.2 | 11,779.2 | 12,073.0 | 12,073.0 | 12,184.8 | 12,184.8 |
| Diabetes-related health expenditure per person, ID | - | - | - | - | 11,779.2 | 11,779.2 | 12,073.0 | 12,073.0 | 12,184.8 | 12,184.8 |
| Demographics | ||||||||||
| Total adult population (20-79 y), in 1,000s | 190,081.0 | 190,081.0 | 216,804.8 | 216,804.8 | 237,306.1 | 237,306.1 | 248,885.6 | 248,885.6 | 257,576.7 | 257,576.7 |
| Population of children (0-14 y), in 1,000s | 59,909.0 | 59,909.0 | - | - | 60,737.0 | 60,737.0 | - | - | - | - |
| Population of children and adolescents (0-19 y), in 1,000s | - | - | - | - | 82,080.9 | 82,080.9 | - | - | - | - |
| Impaired fasting glucose (IFG) estimates (20-79 y) | ||||||||||
| People with IFG, in 1,000s | - | - | - | - | 20,463.7 | 20,463.7 | 21,282.2 | 21,282.2 | 22,528.7 | 22,528.7 |
| Age-adjusted comparative prevalence of IFG, % | - | - | - | - | 8.1 | 8.1 | 8.4 | 8.4 | 8.5 | 8.5 |